Although STAT3 signaling in tumor-associated immune cells is known to play a critical role in suppressing antitumor immune responses, few studies have analyzed STAT3 activity in tumor-surrounding lymphocytes in patient tumors before and after specific treatments. The gene discussed is STAT3; the disease is neoplasm.